Neurol. praxi. 2010;11(4):224-227

Toxic neuropathy

doc.MUDr.Edvard Ehler, CSc., MUDr.Jan Latta
Neurologická klinika, Pardubická krajská nemocnice, a. s.
Fakulta zdravotnických studií, Univerzita Pardubice

We have detected the 2 major trends in toxic neuropathies in our sample-set: i) professional toxic neuropathies incidence has decreased

and ii) the number of drug-induced neuropathies has increased. It was proven that the axonal toxic neuropathies are the most frequent

and long nerves are affected most severely. In clinical findings the lesion of sensory fibers prevails above the motor fibers lesion and

above the signs of autonomic nerve dysfunction. The most important steps in the diagnostic process are the goal adhered history, the

clinical picture, the neurophysiological investigation and blood and urine analysis. If the exposition to the industrial toxin occurred and

is confirmed with the diagnostic process, the cooperation with Centre for occupational medicine is unavoidable. Symptomatic therapy

is always prescribed, with the possible addition of targeted therapy in some toxic neuropathies, to terminate the neurotoxic medication

or stopping the toxic exposition. The basic approach in toxic neuropathies is always the prevention.

Keywords: neurotoxicity, industrial toxins, heavy metals, medicaments, toxic neuropathies

Published: October 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ehler E, Latta J. Toxic neuropathy. Neurol. praxi. 2010;11(4):224-227.
Download citation

References

  1. Amato AA, Russel JA (eds). Neuromuscular disorders. New York: McGraw Hill 2008: 775.
  2. Bleecker ML (ed.) Occupational and clinical neurotoxicology. Baltimore: Williams & Wilkins, 1994: 387.
  3. Ehler E. Periferní neuropatie v ambulantní praxi. Neurol. pro praxi 2009; 10(1): 32-36.
  4. Ehler E, Štětkářová I. Patofyziologie bloku vedení u neuromuskulárních chorob. Česk Slov Neurol N 2008; 71(104): 93-101.
  5. England JD, Asbury AK. Peripheral neuropathy. The Lancet 2004; 363: 2151-2161. Go to original source... Go to PubMed...
  6. Erdem S, Kissel JT, Mendell JR. Toxic neuropathies: drugs, metals, and alcohol. In: Mendell JR, Kissel JT, Cornblath DR (eds). Diagnosis and management of peripheral nerve disorders. Oxford: Oxford Press 2001: 297-343.
  7. Kimura J. (ed) Peripheral nerve diseases. Edinburgh: Elsevier 2006: 972.
  8. King RHM. The pathology of peripheral nerve diseases. ACNR 2006; 6: 16-18.
  9. Lewis RA. Toxic and deficiency neuropathies. Continuum 2003; 9(6): 160-181.
  10. Ludin HP, Tackmann W (eds). Polyneuropathien.StuttgartNew York: Georg Thieme Verlag 1984: 434.
  11. Nodera H, Kaji R. Nerve excitability testing and its clinical application to neuromuscular diseases. Clinical Neurophysiology 2006; 117: 1902-1916. Go to original source... Go to PubMed...
  12. Oh SJ (ed.). Principles of clinical electromyography. Case studies. Baltimore: Williams Wilkins 1998: 604.
  13. Schaumburg H, Albers JW. Identification of neurotoxic disease. Continuum 2008; 14: 11-34. Go to original source...
  14. Stewart JD (ed). Focal peripheral neurpathies. 3rd edition. Philadelphia: Lippincott Williams Wilkins 2000: 580.
  15. Umapathi T, Chaundry V. Toxic neuropathy. Curr Opin Neurol 2005; 18: 574-580. Go to original source... Go to PubMed...
  16. Windebank AJ, Grisold W. Chemotherapy-induces neuropathy. JPNS 2008; 13: 27-46. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.